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A Requirement for Flk1 in Primitive
and Definitive Hematopoiesis
and Vasculogenesis
Fouad Shalaby,1,6,7 Jacqueline Ho,1,2,6 streak stage, groups of mesodermal cells aggregate in
the developing yolk sac to form the extraembryonicWilliam L. Stanford,1 Klaus-Dieter Fischer,1,8
blood islands. Cells at the periphery of these aggregatesAndre C. Schuh,3,5 Lois Schwartz,1
differentiate into endothelial cell precursors (angio-Alan Bernstein,1,2 and Janet Rossant1,2,4
blasts), while cells in the interior become primitive blood1Samuel Lunenfeld Research Institute
cells (Risau, 1991). The close spatial and temporal asso-Mount Sinai Hospital
ciation between the development of these two cell lin-600 University Avenue
eages has led to the hypothesis that they have a com-Toronto, Ontario, Canada M5G 1X5
mon precursor, the ``hemangioblast'' (Sabin, 1920;2Department of Molecular and Medical
Murray, 1932; Wagner, 1980). Although the yolk sac con-Genetics
tains hematopoietic activity as early as 7±8.5 days post-3Department of Medicine
coitum (dpc), these progenitors have limited potentialDepartment of Medical Biophysics
(Moore and Metcalf, 1970; Wong et al., 1986; Liu and4Department of Obstetrics and Gynecology
Auerbach, 1991; Cumano et al., 1993; Huang and Auer-University of Toronto
bach, 1993). Pluripotent HSCs with long-term repopulat-Toronto, Ontario, Canada
ing potential (LTR-HSC) and cells capable of forming5Division of Hematology/Oncology
macroscopic spleen colonies in irradiated recipientsToronto Hospital
(CFU-S) appear later in the yolk sac, between 9 and 11200 Elizabeth Street
dpc (Moore and Metcalf, 1970; Perah and Feldman,Toronto, Ontario, Canada M5G 2C4
1977; Symann et al., 1978; Sonoda et al., 1983; Medvin-
sky et al., 1993; Muller et al., 1994). However, recent
evidence suggests that these cells populate the yolk sacSummary
secondarily from an intraembryonic source. Lymphoid
and multipotent myeloid precursors can develop from
Mouse embryos lacking the receptor tyrosine kinase, the intraembryonic posterior splanchnopleure as early
Flk1, die without mature endothelial and hematopoi- as 7.5 dpc in the absence of any yolk sac circulation
etic cells. To investigate the role of Flk1 during vascu- (Cumano et al., 1996). By 10.5 dpc, LTR-HSCs originate
logenesis and hematopoiesis, we examined the devel- in the embryo proper in the aorta, genital ridge, and
opmental potential of Flk12/2 embryonic stem cells in mesonephros region (AGM), which is lineally related to
chimeras. We show that Flk1 is required cell autono- the earlier posterior splanchnopleure region (Medvinsky
mously for endothelial development. Furthermore, and Dzierzak, 1996). HSCs from this region are then
Flk12/2 cells do not contribute to primitive hematopoi- presumed to colonize both the yolk sac and fetal liver,
esis in chimeric yolk sacs or definitive hematopoiesis where they give rise to definitive hematopoietic precur-
in adult chimeras and chimeric fetal livers. We also sors after 12.5 dpc (Dzierzak and Medvinsky, 1995).
demonstrate thatcells lacking Flk1 are unable to reach An association between vasculogenesis and hemato-
the correct location to form blood islands, suggesting poiesis is clearly seen in the development of the yolk sac
that Flk1 is involved in the movement of cells from the blood islands, but is also present during intraembryonic
posterior primitive streakto the yolk sac and, possibly, hematopoiesis. Explants of embryonic tissue that give
to the intraembryonic sites of early hematopoiesis. rise to hematopoietic progenitors always include the
developing dorsal aorta (Godin et al., 1993, 1995; Med-
Introduction vinsky et al., 1993; Cumano et al., 1996; Medvinsky and
Dzierzak, 1996), and clusters of hematopoieticcells have
During embryogenesis, development of the hemato- been reported intravascularly, contiguous to the inner
poietic system occurs at various anatomical sites, surface of posterior arterial endothelia in the chick (Die-
including the extraembryonicyolk sac, fetal liver, spleen, terlen-Lievre and Martin, 1981) and the mouse (Garcia-
Porrero et al., 1995). This intimate proximity betweenand finally, adult bone marrow. Earlier evidence sug-
endothelial and hematopoietic precursors in the embryogested that both fetal and adult pluripotent hematopoi-
proper is again consistent with the possibility that theseetic stem cells (HSCs) originate in the yolk sac and sub-
two cell lineages are derived from a common precursor.sequently colonize the fetal liver and then the bone
The relationship between vasculogenesis and hema-marrow. More recently, studies in avian, amphibian, and
topoiesis has also been established from the analysis ofnow mouse embryos have supported the view that there
the expression and function of receptor tyrosine kinasesare two discrete anatomic origins of hematopoietic
that are largely expressed in endothelial cells. The Tek/activity, one extraembryonic and one intraembryonic
Tie-2 (Dumont et al., 1992; Sato et al., 1993) and Tie/(Dzierzak and Medvinsky, 1995). During the primitive
Tie-1 (Partanen et al., 1992; Sato et al., 1993) receptors
have similar extracellular domains and define one class
6These authors contributed equally to this work. of endothelial cell-specific tyrosine kinases. These re-7Present address: Bristol-Myers Squibb Pharmaceutical Research
ceptors and their ligands appear to have important rolesInstitute, Princeton, New Jersey, 08543±4000.
in endothelial cell survival, integrity, and function (Du-8Present address: Institute of Medical Radiation and Cell Research,
mont et al., 1994; Puri et al., 1995; Sato et al., 1995;University of Wurzburg, Versbacher Str. 5, Wurzburg, Germany,
97078. Davis et al., 1996; Partanen et al., 1996; Suri et al., 1996)
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but do not affect the initial generation of endothelial concentrations (Mortensen et al., 1992). Two homozy-
precursors. Chimeric analysis has also shown that the gous mutant clones (5547 and 5548) and two heterozy-
development and function of the hematopoietic system gous clones (5539 and 5540) were isolated after the
proceeds normally in the absence of the Tie/Tie-1 recep- selection and were used to generate chimeras. The
tor, although expression of tie and tek has been reported clones were genotyped by PCR amplification of geno-
in hematopoietic cells (Iwama et al., 1993; Batard et al., mic DNA with primers specific for the wild type and the
1996; Hashiyama et al., 1996; Partanen et al., 1996). mutant alleles (Shalaby et al., 1995).
The expression of tek/tie-2 and tie/tie-1 is preceded The targeted Flk1-null allele contains a bacterial lacZ
by that of Flk1 (Matthews et al., 1991; Yamaguchi et al., gene inserted under the transcriptional control of the
1993) and Flt1 (Shibuya et al., 1990). These two recep- endogeneous Flk1 promoter (Shalaby et al., 1995), facili-
tors, along with Flt4, define a secondclass of endothelial tating analysis of the contribution of Flk1 mutant cells to
cell-specific tyrosine kinases based on their structural endothelial lineages in chimeras. Thus, b-galactosidase
similarities. Both the Flk1 and Flt1 receptors bind vascu- staining marks endothelial cells derived from the Flk11/2
lar endothelial growth factor (VEGF) with high affinity or Flk12/2 ES cells in a chimera. Ten Flk11/2 ,2. CD1
(de Vries et al., 1992; Millauer et al., 1993; Quinn et chimeric embryos and 25 Flk12/2 ,2. CD1 chimeric
al., 1993). The early expression of Flk1 and Flt1 in the embryos were stained for b-galactosidase activity. The
developing blood islands of primitive streak stage em- contribution of ES cells was estimated for each chimeric
bryos (Yamaguchi et al., 1993; Fong et al., 1995; Shalaby embryo by GPI analysis on a portion of the embryo and
et al., 1995) is consistent with a dual role for this signaling varied from 10% to 80% (data not shown). b-galactosi-
pathway in the onset of vasculogenesis and hematopoi- dase staining of chimeric embryos at 9.5 dpc demon-
esis in the yolk sac. In addition, Flk1, but not Flt1, is strated that Flk11/2 cells readily contributed to embry-
also expressed in the posterior splanchnopleure (Yama- onic endothelia, such as the endothelium of the dorsal
guchi et al., 1993; Fong et al., 1995; Shalaby et al., 1995) aorta, the endocardium, and the developing vasculature
and in fetal liver hematopoietic precursors (Matthews of the yolk sac (Figures 1A±1F). Expression of Flk1 was
et al., 1991), suggesting that it could play a role in estab- also observed in nonendothelial cells in the base of the
lishing definitive hematopoiesis. allantois and the posterior splanchnopleure region of
Embryos homozygous for the Flk1-null mutation die the embryo (Figure 1D). In contrast, no Flk12/2 cells were
at midsomite stages, lacking both mature endothelial observed in the embryonic or extraembryonic endothe-
and hematopoietic cells, as a result of a failure to form
lia of Flk12/2 ,2. CD1 embryos (Figures 1G±1L). Thus,
blood islands during the primitive streak stage (Shalaby the vasculature in Flk12/2 ,2. CD1 chimeric embryos
et al., 1995). These results clearly demonstrate a role
was entirely derived from wild-type cells. In these em-
for Flk1 in yolk sac hematopoiesis, but these data do not
bryos, b-galactosidase-expressing cells were observed
distinguish whether the hematopoietic defect in these
near locations that normallygive rise to embryonic blood
embryos is primary or is secondary to the lack of a
vessels, including the head mesenchyme, but failed tosuitable endothelial-lined microenvironment. In addi-
form endothelium (Figure 1H). In addition, some lacZ-tion, because the mutation is lethal early in development,
positive mutant cells were seen in ectopic sites, suchany requirement for Flk1 in later adult hematopoiesis
as the neural tube (Figure 1I).could not be assessed.
The chimeric analysis demonstrates that there is anIn this study, we examined the developmental poten-
absolute cell-autonomous requirement for Flk1 in thetial of embryonic stem (ES) cells homozygous for the
development of the embryonic vasculature, consistentFlk1 mutation in chimeras generated by aggregation
with the phenotype of the Flk1 mutant embryos. Thewith wild-type embryos. The endothelia of chimeric em-
inability of Flk12/2 cells to participate in vasculogenesisbryos and mice were always derived from wild-type
in the embryo implies that the endothelial lineages incells, demonstrating a cell-autonomous requirement for
adult chimeras will also be entirely wild type in origin.Flk1 in endothelial cell differentiation. In these chimeras,
We could not assess this directly for all endothelia be-Flk1 mutant cells were also absent in the hematopoietic
cause Flk1 expression, and hence the expression of thelineages derived from the hematopoietic progenitors of
lacZ reporter, is largely downregulated in adult endothe-both theyolk sac and the fetal liver, indicating an intrinsic
lial cells. However, considerable expression persists inrequirement for Flk1 during embryonic and definitive
the glomerular endothelia of the kidney and the growinghematopoiesis. For at least the development of yolk sac
follicles of the ovary. No b-galactosidase staining washematopoiesis, this requirement does not appear to be
detected in these regions in Flk12/2 ,2. CD1 chimerasabsolute, since erythroid colonies were observed in em-
(data not shown). Thus, these results are consistent withbryoid bodies developed from homozygous mutant Flk1
a complete inability to generate mature endothelial cellsES cells in vitro. Finally, we present evidence that the
in the absence of Flk1 signaling.role of Flk1 is to ensure the correct location in the yolk
sac of the mesodermal precursors of the blood islands,
and we suggest that Flk1 may play a similar role during the
Flk1 Mutant Cells Are Deficient in Yolkdevelopment of the intraembryonic blood-forming region.
Sac Hematopoiesis
Because the chimeric embryos had a wild-type yolkResults
sac vasculature, it was possible to ask whether Flk1-
deficient cells have the potential to develop into yolkFlk1-Deficient Cells Do Not Contribute to
sac hematopoietic cells in the presence of a normalthe Endothelial Lineages in Chimeras
endothelial-lined microenvironment. Hematopoietic col-Homozygous Flk12/2 ES cells were generated by select-
ing Flk11/2 ES cells (Shalaby et al., 1995) in high G418 onies obtained from the yolk sacs of chimeras at 9.5
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Figure 1. Analysis of the Contribution of Flk1-Deficient Cells to the Endothelium of 9.5 dpc Chimeras
b-galactosidase whole-mount staining of Flk11/2 ,2. CD1 (A) and Flk12/2 ,2. CD1 (G) 9.5 dpc chimeras. Sections of b-galactosidase-
stained embryos showed lacZ expression in the vasculature of chimeric embryos derived from Flk11/2 ES cells, including blood vessels of
the head (B), the endocardium (C), dorsal aorta (D), intersomitic vessels (E), and yolk sac blood vessels (F). In contrast, chimeric embryos
generated from Flk12/2 ES cells lacked lacZ expression in their endothelia (H±L), although lacZ expression was detected in nonendothelial
cells. Scale bar 5 100 mm.
dpc were examined by GPI analysis (Figure 2). While with Flk12/2 ES cells. Instead, blue cells accumulated
on the surface of the amnion, where Flk1 is not normallythe Flk11/2 cells contributed efficiently toyolk sac hema-
expressed, suggesting that mutant cells were divertedtopoietic colonies, including macrophage, granulocyte-
from their normal yolk sac fate (Figure 3B).macrophage, and mixed granulocyte-macrophage-ery-
throid colonies, Flk12/2 cells from chimeras failed to do
Endothelial and Hematopoietic Developmentso (Figure 2). Four of eleven Flk12/2 chimeric yolk sacs
in Flk1-Deficient Embryoid Bodiesproduced colonies that were entirely derived from wild-
Heterozygous and homozygous mutant Flk1 ES cellstype cells (GPI-BB). In the other seven yolk sacs, a faint
were analyzed for their ability to generate endothelialGPI-AA band was detected, which may represent con-
and hematopoietic cells in vitro. Undifferentiated ES col-tamination from nonhematopoietic cells or a very small
onies were treated with dispase and grown in suspen-proportion of Flk12/2 hematopoietic colonies (Figure
sion in the absence of leukemic inhibitory factor (LIF).2B). Thus, we could detect few, if any, Flk12/2 hemato-
Under these conditions, ES colonies spontaneously dif-poietic progenitors in chimeric yolk sacs, suggesting
ferentiate into cystic embryoid bodies, which resemblethat there is an intrinsic defect in the ability of Flk12/2
the yolk sac in overall morphology and pattern of genecells to colonize extraembryonic hematopoietic lin-
expression (Doetschman et al., 1985; Schmitt et al.,eages.
1991; Wiles and Keller, 1991). Cystic embryoid bodies
from Flk11/2 and Flk12/2 cells were grown and stained
Flk1-Deficient Cells Accumulate in the Amnion for b-galactosidase activity. Although Flk11/2 cystic em-
of 7.5 dpc Chimeras bryoid bodies formed an extensive vascular endothelial
This analysis could not distinguish between whether network (Figure 4A), Flk12/2 cystic embryoid bodies did
Flk1 mutant cells were initially present in the blood is- not (Figure 4B).
lands but failed to differentiate into hematopoietic cells, To determine if the Flk12/2 embryoid bodies contained
or whether they were never in the correct location to hematopoietic cells, precystic embryoid bodies were
contribute to yolk sac hematopoiesis. Because Flk1 is transferred from suspension cultures onto tissue culture
expressed in the common progenitor of the angioblasts plates (Bautch et al., 1996). The attached embryoid
and hematopoietic cells of the blood islands, we could bodies were stained for b-galactosidase activity. The
examine this question further by following expression Flk11/2-attached embryoid bodies developed hemoglo-
of b-galactosidase in chimeras. In situ analysis of both binized blood islands adjacent to vascular endothelium
Flk11/2 and Flk12/2 cells in chimeras at 7.5 dpc showed (Figure 4C). The Flk12/2-attached embryoid bodies also
that Flk11/2 cells readily contributed to the extraembry- generated hemoglobinized blood islands next to the
onic mesoderm fated to become blood islands (Figure b-galactosidase-expressing mesodermal endothelial
3A). In contrast, b-galactosidase staining did not extend cell precursors (Figure 4D). These observations demon-
strate that Flk1-deficient cells do not have a completeover the inner surface of the yolk sac in chimeras made
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Figure 2. Analysis of the Contribution of Flk1-Deficient Cells in 9.5
dpc Chimeric Yolk Sacs Figure 3. Distribution of Flk1-Deficient Cells in 7.5 dpc Chimeric
Hematopoietic colony assays were performed on the yolk sacs of Embryos
9.5 dpc chimeras. Colonies (C) from each yolk sac were pooled,
b-galactosidase staining of 7.5 dpc Flk11/2 ,2. CD1 (A) andFlk12/2
lysed, and analyzed for the presence of the GPI-AA and -BB iso-
,2. CD1 (B) chimeras showed a lack of Flk12/2 cells in the extraem-
forms. The embryos (E) corresponding to each yolk sac were identi- bryonic mesoderm believed to give rise to the blood islands. The
fied as chimeras by GPI as well. Flk11/2 ES cells were able to contrib- Flk11/2 cells readily contributed to the presumptive precursors of
ute to hematopoietic progenitors (A), but Flk12/2 ES cells (B) only the blood islands, but the Flk12/2 cells appeared to be diverted to
did so rarely. other mesodermal populations such as the amnion of these em-
bryos.
block in the generation of hematopoietic cells, but rather contribution of cells of different genotypes to the hema-
can generate at least erythroid cells under these in vitro topoietic system when assayed in mature animals (Ber-
culture conditions. ger et al., 1995). To address this question, we examined
thecontribution of Flk12/2 cells todefinitive hematopoie-
sis during fetal development in 14.5 dpc chimeras. ByDefinitive Hematopoiesis Is Deficient in Flk1
Mutant Chimeras this stage, progenitors with full adult hematopoietic po-
tential are normally present in the fetal liver (MedvinskyThe development of viable Flk12/2 ,2. CD1 chimeras
allowed us to determine whether Flk1 was also required et al., 1993; Muller et al., 1994). Individual tissues from
14.5 dpc chimeras made with Flk12/2 or Flk11/2 ES cellsfor the development of adult hematopoiesis. GPI analy-
sis showed that both Flk11/2 and Flk12/2 ES cells could were analyzed by GPI isozyme analysis to confirm the
chimerism of the embryos (Figures 5E and 5F). Thecontribute to many different adult organs (Figures 5A
and 5B). Samples of peripheral blood, bone marrow, hematopoietic colonies obtained from five 14.5 dpc fetal
livers were entirely wild type (GPI-BB) in chimerasspleen, and thymus tissues of adult chimeras were ana-
lyzed for their GPI isoenzymes. These tissues were es- generated with Flk12/2 ES cells. In contrast, Flk11/2 cells
contributed efficiently to myeloid (macrophage andsentially derived from the wild-type embryo cells (GPI-
BB) in chimeras generated with the Flk12/2 ES cells granulocyte-macrophage) and mixed myeloid-erythroid
colonies from four 14.5 dpc chimeric fetal livers (Figures(Figures 5D and 6). The GPI-AA band observed in some
spleen and thymus preparations was not present in 5E and 5F). Taken together, the chimeric analysis dem-
onstrates that Flk1 is necessary for both primitive andsplenocytes and thymocytes derived from these tissues
and therefore likely represents nonhematopoietic stro- definitive hematopoiesis.
mal cells derived from the Flk12/2 ES cells in these or-
gans. In chimeras generated with the Flk11/2 ES cells, Flk1 Is Expressed in Regions of
Intraembryonic Hematopoiesisthe heterozygous cells contributed efficiently to all he-
matopoietic tissues (Figures 5C and 6). The absence of Flk12/2 cells contributing to definitive
hematopoiesis led us to reexamine whether Flk1 expres-There are two possible models to explain the absence
of Flk12/2 cells in the hematopoietic compartment of sion marks the putative early sites of intraembryonic
hematopoiesis. Examination of b-galactosidase expres-adult chimeras. First, Flk1 mutant cells may be unable to
contribute to the generation of definitive hematopoietic sion in Flk11/2 embryos between 8.5 and 10.5 days of
gestation revealed broad expression of Flk1 in the pos-progenitors. Alternatively, HSCs may differentiate from
Flk12/2 cells at earlier developmental stages, but these terior splanchnopleure, as previously reported (Figure
7) (Yamaguchi et al., 1993; Shalaby et al., 1995). Withinclones may then be subsequently selected against in the
presence of wild-type cells in chimeric animals. There is this region, there were small clumps of isolated lacZ-
positive cells, which might represent specific hemato-considerable evidence from chimeric mouse studies
that selective effects can cause marked skewing in the poietic precursors (Figure 7A). In slightly older embryos,
Flk1 Is Required for Hematopoiesis
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Figure 4. Hematopoietic Development in the
Absence of Mesodermal Migration in Flk1-
Deficient Embryoid Bodies
In vitro differentiation and b-galactosidase
staining of Flk11/2 ES cells (A and C) and
Flk12/2 ES cells (B and D). The Flk11/2 cells
form an extensive vascular endothelial net-
work in cystic embryoid bodies (A), whereas
Flk12/2 cells form endothelial cell precursors
but do not form mature endothelial cells in
cystic embryoid bodies (B). Day 8 attached
embryoid bodies demonstrate that both
Flk11/2 (C) and Flk12/2 (D) ES cells are capa-
ble of primitive hematopoiesis as defined by
the formation of hemoglobinized blood is-
lands.
where hematopoieticpotential has been associated with was confined to areas where Flk1 is expressed in nonen-
dothelial cells, such as the base of the allantois andthe AGM region, small clumps of strongly lacZ-positive
cells were observed intravascularly in the omphalomes- cells in the branchial arches. Some blue cells were also
seen in ectopic sites in mutant but not heterozygousenteric artery, apparently in close association with the
endothelial lining (Figures 7B±7D). Histological studies chimeras, suggesting that endothelial precursors lack-
ing the ability to signal through Flk1 may not die buthave suggested that these cellsmay be the intraembryo-
nic hematopoietic progenitors (Garcia-Porrero et al., rather may be redirected into other fates.
The generation of chimeras with wild type endothelia1995).
allowed us to ask whether Flk1 was directly required for
the early development of the hematopoietic system. AsDiscussion
judged by GPI isozyme contribution, Flk12/2 cells were
strongly underrepresented in the in vitro colonies repre-Both endothelial and hematopoietic cells fail to develop
senting the primitive hematopoietic progenitors derivedin mouse embryos lacking the Flk1 receptor tyrosine
kinase, and embryos die by 9.5 days of gestation, pre-
cluding a detailed analysis of the functions of this signal-
ing pathway during development (Shalaby et al., 1995).
By generating chimeras between Flk1 mutant ES cells
and wild-type embryos, we have been able to rescue
the mutant phenotype and provide insights into the roles
of Flk1 signaling in both endothelial development and
hematopoiesis. Flk1-deficient ES cells were incapable
of developing into endothelial cells at any stage of devel-
opment analyzed, as judged by the expression of the
b-galactosidase reporter that was introduced during the
disruption of the Flk1 gene. Flk12/2 cells were absent
in the dorsal aorta, cardinal veins, intersomitic arteries,
and yolk sac blood vessels of chimeric embryos as early
as 9.5 dpc, consistent with the previously observed lack
of mature endothelium in Flk1 mutant embryos (Shalaby Figure 5. GPI Analysis of the Contribution of Flk11/2 and Flk12/2
et al., 1995). They could, however, effectively contribute Cells to Hematopoietic Lineages in Chimeric Mice
to various other tissues and cell types examined, pro- GPI isoenzyme analysis of various tissues taken from a Flk11/2
,2. CD1 chimera (A) and from a Flk12/2 ,2. CD1 chimera (C)ducing viable adult chimeric mice. Based on these re-
demonstrates that the Flk1 ES cells are pluripotent. GPI analysis ofsults, we conclude that Flk1 is required cell autono-
various hematopoietic tissues from a chimera generated with Flk11/2mously for endothelial development, both within the
ES cells (B), and one generated with Flk12/2 ES cells (D), shows thatembryo and in extraembryonic locations. Interestingly,
Flk12/2 cells are incapable of contributing to hematopoietic tissues.
b-galactosidase expression indicative of activation of Colonies from the fetal livers of four Flk11/2 ,2. CD1 chimeras (E)
Flk1 expression was still observed in chimeras con- and five Flk12/2 ,2. CD1 chimeras were pooled and analyzed for
the presence of GPI isoenzymes (F). L, limb; C, colonies.taining Flk1-null mutant cells. However, such expression
Cell
986
Figure 6. Distribution of the Flk11/2 and
Flk12/2 Cells to Various Tissues from Chime-
ric Mice
Tissues of chimeras obtained by aggregation
of wild-type CD1 embryos and the Flk11/2
and Flk12/2 ES cells were electrophoresed on
cellulose acetate membranes. The contribu-
tion of ES cells to each tissue was estimated
visually and categorized as follows: 0%, open
boxes; 1%±25%, hatched boxes; 26%±50%,
shaded boxes; 51%±75%, checkered boxes;
or 76%±100%, closed boxes. ND, no data.
Flk1-deficient cells failed to contribute to he-
matopoietic lineages.
from chimeric yolk sacs. The low contribution from the is possible that mesoderm cells respond to other signals
and thereby become committed to alternative fates.mutant cells may reflect true contribution by Flk12/2
cells to yolk sac hematopoiesis, or may simply be due Thus, Flk1 may indeed be required in a common precur-
sor of both hematopoietic and endothelial lineages, butto the presence of some nonhematopoietic cells in the
yolk sac that survived the in vitro culture conditions. In this precursor may be a pluripotent, not bipotent, meso-
derm cell that has multiple developmental options.either case, there was clearly a major deficiency in the
primitive hematopoietic potential of Flk12/2 cells. These The failure of Flk1 mutant mesoderm cells to colonize
the blood islands raises the question of whether Flk12/2data argue for either a dual role for Flk1 signaling in the
progenitor cells of both the endothelial and hematopoi- cells could differentiate into primitive hematopoietic
progenitors if they were located in the right environment.etic lineages, or for a common Flk1-dependent precur-
sor of both lineages. Examination of embryoid body differentiation of Flk12/2
ES cells confirmed the inability of endothelialcell precur-Primitive hematopoietic and endothelial progenitors
arise within the yolk sac blood islands from precursor sors to develop into mature blood vessels. However,
the Flk12/2 ES cells were able to form hemoglobinizedcells that all appear to express Flk1 (Shalaby et al.,
1995). lacZ-expressing Flk12/2 cells were not seen in blood islands adjacent to the lacZ-expressing endothe-
lial cell precursors, suggesting that Flk12/2 mesodermalthe developing blood islands of the yolk sac at 7.5 dpc,
suggesting that Flk12/2 cells are excluded from the cells have the capability to differentiate into primitive
erythroid progenitors. Indeed, more detailed analysisblood islands and hence fail to contribute to both yolk
sac endothelial and hematopoietic lineages. As within suggests that under such in vitro conditions, ES cell-
derived Flk12/2 and Flk11/2 primitive hematopoiesis isthe embryo itself at later stages, lacZ-expressing cells
were observed in the chimeras, but they appear to be indistinguishable (A.C. S. et al.,unpublished data). Thus,
a comparison of the in vitro embryoid body data anddiverted to other mesoderm populations such as the
amnion. We propose that activation of Flk1 signaling is the in vivo chimeric data suggests that Flk1 signaling is
not necessarily required in a cell-autonomous mannerrequired as cells exit the posterior primitive streak if
these cells are to move to the correct yolk sac location, for primitive hematopoiesis per se, but for ensuring that
mesodermal progenitors are placed in the right environ-where they are then able to undergo further develop-
ment into endothelial and hematopoietic progenitors. ment to respond to the appropriate signals for hemato-
poiesis. This contrasts with the autonomous role for Flk1The ligand for Flk1, VEGF, is expressed in the endoderm
of the yolk sac and may attract cells to this location in the endothelial lineages. In mutant and in chimeric
embryos, Flk12/2 precursors are observed in the correct(Dumont et al., 1995). In the absence of such signaling, it
Flk1 Is Required for Hematopoiesis
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be a direct consequence of the earlier absence of yolk
sac progenitors. However, recent work has convincingly
supported the idea of a separate intraembryonic origin
for definitive hematopoiesis in mice, as in other verte-
brates (Godin et al., 1993, 1995; Medvinsky et al., 1993;
Medvinsky and Dzierzak, 1996). The presence of LTR-
HSCs in the isolated AGM in organ culture has demon-
strated that this region is capable of initiating definitive
hematopoiesis without cellular exchange with the yolk
sac (Medvinsky and Dzierzak, 1996). Furthermore, when
the paraaortic splanchnopleure region is isolated and
cultured before circulation begins, the presence of
lymphoid and myeloid progenitors can be detected (Cu-
mano et al., 1996). In the light of this evidence supporting
a separate origin for definitive hematopoietic progeni-
tors, the absence of Flk12/2 cells in the adult hematopoi-
etic system suggests that Flk1 plays a separate role in
definitive hematopoiesis.
The nature of the requirement for Flk1 signaling in
the development of the adult hematopoietic system is
unclear. Flk1 is expressed in fetal liver hematopoietic
progenitors (Matthews et al., 1991) and may therefore
play an intrinsic role in definitive hematopoiesis. How-
ever, given the association between blood vessels and
hematopoietic progenitors in the AGM, and evidence
presented here that Flk1 is expressed in putative hema-
Figure 7. Flk1 Expression in 8.5 and 9.5 dpc Embryos
topoietic precursors in the AGM, as well as the devel-
b-galactosidase staining of 8.5 and 9.5 dpc Flk11/2 embryos. Iso-
oping vessels, it is also possible that Flk1 may be actinglated Flk1-expressing cells (arrow) were detected in the posterior
within the embryo in a similar manner to its role in extra-splanchnopleure of 8.5 dpc embryos (A). Histological transverse
embryonic hematopoiesis, namely to regulate the devel-sections through 9.5 dpc Flk11/2 embryos showed a clump of lacZ-
positive cells (arrows) in the omphalomesenteric artery (B), as well opmental behavior of the common precursor of the he-
as near the connection of this artery with the posterior dorsal aorta matopoietic and angioblast lineages. A role for VEGF
(C). Scale bar 5 100 mm. These clumps appear in close association signaling in promoting development of the earliest he-
with the endothelial lining of the artery (D). Scale bar 5 50 mm.
matopoietic progenitors has also recently been pro-
posed (Kennedy et al., 1997) based on the effects of
embryonic location in the head mesenchyme, where VEGF on the differentiation of ES cells in vitro.
they would develop into embryonic blood vessels but A role for Flk1 signaling in both yolk sac and definitive
fail to do so. Similarly, in embryoid bodies, Flk12/2 cells hematopoieisis contrasts with the role for signaling
fail to form mature blood vessels, even though they do through the Kit receptor tyrosine kinase, which appears
not have to undergo the morphogenetic events of streak to be restricted to definitive hematopoiesis. Mutations
formation. Thus, there appears to be an absolute re- in the c-kit gene (mouse W locus) lead to multiple devel-
quirement for Flk1 in the specification of the endothelial
opmental abnormalities, including defects in hemato-
lineages, and an additional earlier role in the allocation
poiesis (for review, see Russell, 1979; Reith and Bern-
of the progenitors of the extraembryonic blood islands.
stein, 1991). Mice injected with anti-Kit antibody do not
The derivation of viable chimeras allowed us to exam-
display overt YS hematopoietic defects, suggesting that
ine whether Flk1 was also required for definitive hemato-
the Kit receptor is not required for YS hematopoiesispoiesis in vivo. Flk1-deficient ES cells were not detected
(Ogawa et al., 1993). Recently, Sanchez et al. (1996)among bone marrow cells, peripheral blood, spleno-
have demonstrated that the Kit receptor tyrosine kinasecytes,or thymocytes in adult chimeras, norcould Flk12/2
is expressed on hematopoietic stem cells in the AGMhematopoietic progenitors be detected in the fetal livers
region. It is interesting to note that Flk1 and c-kit mapof Flk12/2 ,2. CD1 chimeras. Thus, we conclude that
within 2 Mb in both the mouse and human genomesthere is an intrinsic requirement for Flk1 signaling during
(Spritz et al., 1994; Brunkow et al., 1995). Thus, justthe development of the progenitors of the adult hemato-
as the genes within the b-globin gene cluster undergopoietic system. The absence of Flk12/2 cells from all
switching during the transition from primitive to defini-compartments of the hematopoietic system, along with
tive hematopoiesis, there may also be a transitionthe inability to detect Flk12/2 hematopoietic progenitors
from an early requirement for Flk1 through a dual re-in in vitro colony assays, suggests there is an early
quirement for Flk1 and the closely linked Kit receptorrequirement for Flk1 in the generation of the pluripotent
in fetal hematopoiesis, followed by a reliance on Kitadult HSC.
signaling in adult life.Until recently, it was widely accepted that pluripotent
Although many different regulators of hematopoieticHSCs first arise in the yolk sac, then migrate to the fetal
development have been identified, mutational analysisliver, and finally colonize the bone marrow (Moore and
has shown that most have roles confined to the develop-Metcalf, 1970; for review, see Dzierzak and Medvinsky,
ment of definitive hematopoiesis. However, mutations1995). According to this view, the absence of adult he-
matopoietic cells in Flk12/2 ,2. CD1 chimeras would in the SCL/tal-1 and rbtn2 transcription factor genes
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from one fetal liver were scored visually and pooled for GPI analysisboth lead to defects in early yolk sac hematopoiesis
on day 10 of incubation.(Warren et al., 1994; Shivdasani et al., 1995). Chimeric
analysis has shown that SCL/tal-1 is also required for
In Vitro Differentiation of ES Cellsdefinitive hematopoiesis (Porcher et al., 1996), showing
In vitro differentiation of ES cells was performed as previously de-
that some aspects of the transcriptional programs in scribed (Bautch et al., 1996). In brief, ES cells were passaged twice
both primitive and definitive hematopoietic progenitors on gelatinized plates. On day 6, after the second passage, ES colo-
are shared. Our evidence suggests that signaling nies were treated with dispase, washed, and grown in suspension
in bacterial dishes in ES media without LIF. For attached embryoidthrough Flk1 is also a common property of early progeni-
body cultures, embryoid bodies were transferred to tissue culturetors of both types of hematopoietic cells. A further
plates on day 3 postdispase treatment. On day 8 postdispase treat-understanding of the Flk1 signaling pathway and how
ment, b-galactosidase activity was detected as before.
it affects the behavior of mesodermal precursors of the
endothelial and hematopoietic lineages may thus shed
Acknowledgments
light on the fundamental mechanisms of acquisition of
hematopoietic potential. We would like to thank Ken Harpal for the preparation of excellent
histological sections. J. H. holds a Natural Sciences and Engineering
Research Council Scholarship, W. L. S. is a Leukemia Society of
Experimental Procedures America Fellow, A. C. S. is a Medical Research Coucil (MRC) Scholar,
and J. R. is a Terry Fox Cancer Research Scientist of the National
Production of Flk12/2 ES Cells and Chimeras Cancer Institute of Canada (NCIC) and a Howard Hughes Medical
ES cells heterozygous for the Flk1-null allele (Shalaby et al., 1995) Institute International Research Scholar. Work from the authors'
were seeded at 5 3 104 cells/100 mm plate in ES cell medium (Wurst laboratories is supported by Bristol-Myers Squibb Inc., the NCIC,
and Joyner, 1993). One day later, 640 mg/ml of G418 was added to and the MRC.
the medium. Colonies were picked after one week and screened
for homozygosity at the Flk1 mutant allele by Southern blot and
Received March 11, 1997; revised May 1, 1997.PCR analysis. Three primers were used for PCR amplification as
previously described (Shalaby et al., 1995).
ReferencesES cell lines that were either homozygous or heterozygous for
the Flk1-null allele (which are also glucose phosphate isomerase
Batard, P., Sansilvestri, P., Scheinecker, C., Knapp, W., Debili, N.,isotype Gpi-1aa) were aggregated with CD1 (Gpi-1bb) embryos, and
Vainchenker, W., Buhring, H.J., Monier, M.N., Kukk, E., Partanen,the aggregates transferred into pseudopregnant females (Nagy and
J., et al. (1996). The Tie receptor tyrosine kinase is expressed byRossant, 1993).
human hematopoietic progenitor cells and by a subset of megakary-
ocytic cells. Blood 87, 2212±2220.
Glucose Phosphate Isomerase Isoenzyme Analysis
Bautch, V.L., Stanford, W.L., Rapoport, R., Russell, S., Byrum, R.S.,and b-galactosidase Staining of Cells and Tissues
and Futch, T.A. (1996). Blood island formation in attached culturesCells and tissue lysates were freeze thawed in water as described
of murine embryonic stem cells. Dev. Dyn. 205, 1±12.by Nagy and Rossant (1993). Bone marrow cells were obtained by
Berger, C.N., Tam, P.P., and Sturm, K.S. (1995). The developmentflushing the femur with 1 ml of phosphate-buffered saline. Spleno-
of haematopoietic cells is biased in embryonic stem cell chimaeras.cytes and thymocytes were obtained by teasing the spleen and the
Dev. Biol. 170, 651±663.thymus with forceps and collecting the released cells in 10 ml PBS.
Erythrocytes were removed from these cell preparations by specific Brunkow, M.E., Nagle, D.L., Bernstein, A., and Bucan, M. (1995). A
lysis in 0.16 Mammonium chloride on ice until the cell pelletobtained 1.8-Mb YAC contig spanning three members of the receptor tyrosine
by centrifugation was visually free of erythrocytes. kinase gene family (Pdgfra, Kit, and Flk1) on mouse chromosome
The samples were subjected to electrophoresis on cellulose 5. Genomics 25, 421±432.
acetate plates (cat. no. 3024, Helena Laboratories), and the GPI Cumano, A., Furlonger, C., and Paige, C.J. (1993). Differentiation
isoenzyme bands were visualized as previously described (Nagy and characterization of B-cell precursors detected in the yolk sac
and Rossant, 1993). The contribution of ES cells to the samples was and embryo body of embryos beginning at the 10- to 12-somite
visually estimated by comparison to a set of standard mixtures of stage. Proc. Natl. Acad. Sci. USA 90, 6429±6433.
GPI-AA and GPI-BB cells. Cumano, A., Dieterlen-Lievre, F., and Godin, I. (1996). Lymphoid
Embryos and adult tissues were fixed,stained for lacZ expression, potential, probed before circulation in mouse, is restricted to caudal
and counterstained as previously described (Shalaby et al., 1995). intraembryonic splanchnopleura. Cell 86, 907±916.
Davis, S., Aldrich, T.H., Jones, P.F., Acheson, A., Compton, D.L.,
Hematopoietic Colony Assays Jain, V., Ryan, T.E., Bruno, J., Radziejewski, C., Maisonpierre, P.C.,
Individual yolk sacs from 9.5 dpc chimeric embryos were treated and Yancopoulos, G.D. (1996). Isolation of Angiopoietin-1, a ligand
with 0.5 ml of 0.1% collagenase/20% fetal calf serum for 3.5 hr at for the TIE2 receptor, by secretion-trap expression cloning. Cell 87,
378C as described (Wong et al., 1986) and disaggregated with a 1161±1169.
26-gauge needle. The cells were then plated in 1.5 ml of 0.9% de Vries, C., Escobedo, J.A., Ueno, H., Houck, K., Ferrara, N., and
methylcellulose (Methocult, Stem Cell Technologies) in IMDM Williams, L.T. (1992). The fms-like tyrosine kinase, a receptor for
(GIBCO) supplemented with 25% FCS (Hyclone), 4.5 3 1024 M mo- vascular endothelial growth factor. Science 255, 989±991.
nothioglycerol, 2 U/ml murine erythropoietin (Boehringer), and 2%
Dieterlen-Lievre, F., and Martin, C. (1981). Diffuse intraembryonicIL-3-conditioned medium (Karasuyama and Melchers, 1988). Corre-
hemopoiesis in normal and chimeric avian development. Dev. Biol.sponding embryos were analyzed by GPI to determine the degree
88, 180±191.of chimerism. Colonies were incubated in a humidified CO2 atmo-
Doetschman, T.C., Eistetter, H., Katz, M., Schmidt, W., and Kemler,sphere at 378C, scored visually at day 10, and all colonies from one
R. (1985). The in vitro development of blastocyst-derived embryonicyolk sac were pooled for GPI analysis.
stem cell lines: formation of visceral yolk sac, blood islands andFetal livers from 14.5 dpc chimeric embryos were disaggregated
myocardium. J. Embryol. Exp. Morph. 87, 27±45.with a 26-gauge needle in 1 ml IMDM and plated on semisolid
medium as described above at 1±5 3 105 cells/ml. Viable cells were Dumont, D.J., Yamaguchi, T.P., Conlon, R.A., Rossant, J., and Breit-
man, M.L. (1992). tek, a novel tyrosine kinase gene located on mousecounted with Trypan blue (GIBCO). The growth factors added were
2 U/ml erythropoietin, 0.2 ng/ml GM-CSF (Pharmingen), and IL-3 chromosome 4, is expressed in endothelial cells and their presump-
tive precursors. Oncogene 7, 1471±1480.(Karasuyama and Melchers, 1988). The colonies that were produced
Flk1 Is Required for Hematopoiesis
989
Dumont, D.J., Gradwohl, G., Fong, G.H., Puri, M.C., Gertsenstein, Nagy, A., and Rossant, J. (1993). Production of completely ES cell
derived fetuses. In Gene Targeting: A Practical Approach, A. Joyner,M., Auerbach, A., and Breitman, M.L. (1994). Dominant-negative and
targeted null mutations in the endothelial receptor tyrosine kinase, ed. (New York: IRL Press), pp. 147±179.
tek, reveal a critical role in vasculogenesis of the embryo. Genes Ogawa, M., Nishikawa, S., Yoshinaga, K., Hayashi, S., Kunisada, T.,
Dev. 8, 1897±1909. Nakao, J., Kina, T., Sudo, T., Kodama, H., and Nishikawa, S. (1993).
Expression and function of c-Kit in fetal hemopoietic progenitorDumont, D.J., Fong, G.H., Puri, M.C., Gradwohl, G., Alitalo, K., and
Breitman, M.L. (1995). Vascularization of the mouse embryo: a study cells: transition from the early c-Kit-independent to the late c-Kit-
dependent wave of hemopoiesis in the murine embryo. Develop-of flk-1, tek, tie, and vascular endothelial growth factor expression
during development. Dev. Dyn. 203, 80±92. ment 117, 1089±1098.
Partanen, J., Armstrong, E., Makela, T.P., Korhonen, J., Sandberg,Dzierzak, E., and Medvinsky, A. (1995). Mouse embryonic haemato-
poiesis. Trends Genet. 11, 359±366. M., Renkonen, R., Knuutila, S., Huebner, K., and Alitalo, K. (1992).
A novel endothelial cell surface receptor tyrosine kinase with extra-Fong, G.H., Rossant, J., Gertsenstein, M., and Breitman, M.L. (1995).
cellular epidermal growth factor homology domains. Mol. Cell. Biol.Role of the Flt-1 receptor tyrosine kinase in regulating the assembly
12, 1698±1707.of vascular endothelium. Nature 376, 66±70.
Partanen, J., Puri, M.C., Schwartz, L., Fischer, K.-D., Bernstein, A.,Garcia-Porrero, J.A., Godin, I.E., and Dieterlen-Lievre, F. (1995). Po-
and Rossant, J. (1996). Cell autonomous functions of the receptortential intraembryonic hemogenic sites at pre-liver stages in the
tyrosine kinase TIE in a late phase of angiogenic capillary growthmouse. Anat. Embryol. 192, 425±435.
and endothelial cell survival during murine development. Develop-Godin, I.E., Garcia-Porrero, J.A., Coutinho, A., Dieterlen-Lievre, F.,
ment 122, 3013±3021.and Marcos, M.A.R. (1993). Para-aortic splanchnopleura from early
Perah, G., and Feldman, M. (1977). In vitro activation of the in vivomouse embryos contains B1a cell progenitors. Nature 364, 67±69.
colony-forming units of the mouse yolk sac. J. Cell. Physiol. 91,Godin, I., Dieterlen-Lievre, F., and Cumano, A. (1995). Emergence
193±199.of multipotent hemopoietic cells in the yolk sac and paraaortic
Porcher, C., Swat, W., Rockwell, K., Fujiwara,Y., Alt, F.W., and Orkin,splanchnopleura in mouse embryos, beginning at 8.5 days post-
S.H. (1996). The T cell leukemia oncoprotein SCL/tal-1 is essentialcoitus. Proc. Natl. Acad. Sci. USA 92, 773±777.
for development of all hematopoietic lineages. Cell 86, 47±57.Hashiyama, M., Iwama, A., Ohshiro, K., Kurozumi, K., Yasunaga, K.,
Puri, M., Rossant, J., Alitalo, K., Bernstein, A., and Partanen, J.Shimizu, Y., Masuho, Y., Matsuda, I., Yamaguchi, N., and Suda, T.
(1995). The receptor tyrosine kinase TIE is required for integrity and(1996). Predominant expression of a receptor tyrosine kinase, TIE,
survival of vascular endothelial cells. EMBO J. 14, 5884±5891.in hematopoietic stem cells and B cells. Blood 87, 93±101.
Quinn, T.P., Peters, K.G., De Vries, C., Ferrara, N., and Williams, L.T.Huang, H., and Auerbach, R. (1993). Identification and characteriza-
(1993). Fetal liver kinase 1 is a receptor for vascular endothelialtion of hematopoietic stem cells from the yolk sac of the early mouse
growth factor and is selectively expressed in vascular endothelium.embryo. Proc. Natl. Acad. Sci. USA 90, 10110±10114.
Proc. Natl. Acad. Sci. USA 90, 7533±7537.Iwama, A., Hamaguchi, I., Hashiyama, M., Murayama, Y., Yasunaga,
Reith, A., and Bernstein, A. (1991). Molecular biology of the W andK., and Suda, T. (1993). Molecular cloning and characterization of
Steel loci. In Genome Analysis 3: Genes and Phenotypes, K. Daviesmouse TIE and TEK receptor tyrosine kinase genes and their expres-
and S. Tilghman, eds. (Cold Spring Harbor, New York: Cold Springsion in hematopoietic stem cells. Biochem. Biophys. Res. Commun.
Harbor Laboratory Press), pp. 105±133.195, 301±309.
Risau, W. (1991). Embryonic angiogenesis factors. Pharmac. Ther.Karasuyama, H., and Melchers, F. (1988). Establishment of mouse
51, 371±376.cell lines which constitutively secrete large quantities of interleukin
2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immu- Russell, E.S. (1979). Hereditary anemias of the mouse: a review for
nol. 18, 97±104. geneticists. Adv. Genet. 20, 357±459.
Kennedy, M., Firpo, M., Choi, K., Wall, C., Robertson, S., Kabrun, Sabin, F. (1920). Studies on the origin of blood vessels and of red
N., and Keller, G. (1997). A common precursor for primitive erythro- blood corpuscles as seen in the living blastoderm of chicks during
poiesis and definitive haematopoiesis. Nature 386, 488±493. the second day of incubation. Contrib. Embryol. Carnegie Inst.
Wash. 9, 214±262.Liu, C.P., and Auerbach, R. (1991). In vitro development of murine T
cells from prethymic and preliver embryonic yolk sac hematopoietic Sanchez, M.-J., Holmes, A., Miles, C., and Dzierzak, E. (1996). Char-
stem cells. Development 113, 1315±1323. acterization of the first definitive hematopoietic stem cells in the
AGM and the liver of the mouse embryo. Immunity 5, 513±525.Matthews, W., Jordan, C.T., Gavin, M., Jenkins, N.A., Copeland,
N.G., and Lemischka, I.R. (1991). A receptor tyrosine kinase cDNA Sato, T.N., Qin, Y., Kozak, C.A., and Audus, K.L. (1993). Tie-1 and
isolated from a population of enriched primitive hematopoietic cells tie-2 define another class of putative receptor tyrosine kinase genes
and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. expressed in early embryonic vascular system. Proc. Natl. Acad.
USA 88, 9026±9030. Sci. USA 90, 9355±9358.
Medvinsky, A., and Dzierzak, E. (1996). Definitive hematopoiesis is Sato, T.N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara,
autonomously initiated by the AGM region. Cell 86, 897±906. Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., and
Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1Medvinsky, A.L., Samoylina, N.L., Muller, A.M., and Dzierzak, E.A.
(1993). An early pre-liver intraembryonic source of CFU-S in the and Tie-2 in blood vessel formation. Nature 376, 70±74.
developing mouse. Nature 364, 64±67. Schmitt, R.M., Bruyns, E., and Snodgrass, H.R. (1991). Hematopoi-
etic development of embryonic stem cells in vitro: cytokine andMillauer, B., Wizigmann-Voos, S., SchnuÈrch, H., Martinez, R., Mùller,
N.P.H., Risau, W., and Ullrich, A. (1993). High affinity VEGF binding receptor gene expression. Genes Dev. 5, 728±740.
and developmental expression suggest Flk-1 as a major regulator Shalaby, F., Rossant, J., Yamaguchi, T.P., Gertsenstein, M., Wu,
of vasculogenesis and angiogenesis. Cell 72, 835±846. X.F., Breitman, M.L., and Schuh, A.C. (1995). Failure of blood-island
formation and vasculogenesis in Flk-1-deficient mice. Nature 376,Moore, M.A., and Metcalf, D. (1970). Ontogeny of the haemopoietic
system: yolk sac origin of in vivo and in vitro colony forming cells 62±66.
in the developing mouse embryo. Br. J. Haematol. 18, 279±296. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsu-
shima, H., and Sato, M. (1990). Nucleotide sequence and expressionMortensen, R.M., Conner, D.A., Chao, S., Geisterfer-Lowrance, A.A.,
and Seidman, J.G. (1992). Production of homozygous mutant ES of a novel human receptor-type tyrosine kinase (flt) closely related
to the fms family. Oncogene 5, 519±524.cells with a single targeting construct. Mol. Cell. Biol. 12, 2391±2395.
Muller, A.M., Medvinsky, A., Strouboulis, J., Grosveld, F., and Dzier- Shivdasani, R.A., Mayer, E.L., and Orkin, S.H. (1995). Absence of
blood formation in mice lacking the T-cell leukaemia oncoproteinzak, E. (1994). Development of hematopoietic stem cell activity in
the mouse embryo. Immunity 1, 291±301. tal-1/SCL. Nature 373, 432±434.
Sonoda, T., Hayashi, C., and Kitamura, Y. (1983). Presence of mastMurray, P.D.F. (1932). The development in vitro of the blood of the
early chick embryo. Proc. R. Soc. Lond. 11, 497±521. cell precursors in the yolk sac of mice. Dev. Biol. 97, 89±94.
Cell
990
Spritz, R.A., Strunk, K.M., Lee, S.T., Lu-Kuo, J.M., Ward, D.C., Le
Paslier, D., Altherr, M.R., Dorman, T.E., and Moir, D.T. (1994). A YAC
contig spanning a cluster of human type III receptor protein tyrosine
kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12.
Genomics 22, 431±436.
Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C.,
Davis, S., Sato, T.N., and Yancopoulos, G.D. (1996). Requisite role
of Angiopoietin-1, a ligand for the TIE2 receptor, during embryonic
angiogenesis. Cell 87, 1171±1180.
Symann, M., Anckaert, M.A., Cordier, A., Rodhain, J., and Sokal, G.
(1978). Murine yolk sac hematopoiesis studied with the diffusion
chamber technique. Exp. Hematol. 6, 749±759.
Wagner, R.C. (1980). Endothelial cell embryology and growth. Adv.
Microcirc. 9, 45±75.
Warren, A.J., Colledge, W.H., Carlton, M.B.L., Evans, M.J., Smith,
A.J.H., and Rabbitts, T.H. (1994). The oncogenic cysteine-rich LIM
domain protein Rbtn2 is essential for erythroid development. Cell
78, 45±57.
Wiles, M.V., and Keller, G. (1991). Multiple hematopoietic lineages
develop from embryonic stem (ES) cells in culture. Development
111, 259±267.
Wong, P.M., Chung, S.W., Chui, D.H., and Eaves, C.J. (1986). Proper-
ties of the earliest clonogenic hemopoietic precursors to appear in
the developing murine yolk sac. Proc. Natl. Acad. Sci. USA 83,
3851±3854.
Wurst, W., and Joyner, A. (1993). Production of targeted embryonic
stem cellclones. In Gene Targeting: A PracticalApproach, A. Joyner,
ed. (New York: IRL Press), pp. 33±61.
Yamaguchi, T.P., Dumont, D.J., Conlon, R.A., Breitman, M.L., and
Rossant, J. (1993). flk-1, an flt-related receptor tyrosine kinase is
an early marker for endothelial cell precursors. Development 118,
489±498.
